Shilpa Sant
Papers
1
Total Citations
57
H-Index
1
About
Shilpa Sant is a pioneering researcher at the intersection of drug delivery, biomaterials, and tissue engineering. Her work has fundamentally advanced the development of microarray-based platforms for high-throughput screening, making these powerful tools accessible beyond centralized facilities. Her most cited study, “Drug-Eluting Microarrays for Cell-Based Screening of Chemical-Induced Apoptosis” (2011, 57 citations), introduced a simple, scalable microarray design that eliminates the need for complex robotic systems, democratizing cell-based assays for apoptosis screening. This innovation enables researchers to rapidly evaluate drug efficacy and toxicity with minimal infrastructure. Beyond this, Sant’s contributions extend to engineering smart biomaterials for controlled drug release and regenerative medicine, with her work collectively garnering significant recognition in the field. Her achievements include developing nanoparticle-based systems for targeted cancer therapy and creating 3D culture models that better mimic in vivo environments. By bridging materials science and cellular biology, Sant has empowered a broader scientific community to conduct sophisticated drug screening, accelerating the discovery of therapeutic candidates and advancing personalized medicine approaches.
Research Focus
Key Achievements
Top Papers
- 1